Advertisement

Topics

Global Academic and NonProfit Partnering Terms and Agreements 20122018: Deal trends, players and financials [Report Updated: 01032018] Prices from USD $2995

17:04 EDT 14 Mar 2018 | BioPortfolio Report Blog

Global Academic and NonProfit Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Academic and NonProfit partnering deals. These deals tend to be multicomponent, starting with collaborative RD, and proceed to commercialization of outcomes.


This report provides details of the latest Academic and NonProfit agreements announced in the life sciences since 2012.


The report takes the reader through a comprehensive review Academic and NonProfit deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Academic and NonProfit partnering deals.


The report presents financial deal term values for Academic and NonProfit deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.


The middle section of the report explores the leading dealmakers in the Academic and NonProfit partnering field; both the leading deal values and most active Academic and NonProfit dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.


One of the key highlights of the report is that over 4,000 online deal records of actual Academic and NonProfit deals, as disclosed by the deal parties, are included towards the end of the report in a directory format by company AZ, stage of development, deal type, therapy focus, and technology type that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.


In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases and databases do not.


The initial chapters of this report provide an orientation of Academic and NonProfit dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Academic and NonProfit dealmaking since 2012, including details of headline, upfront, milestone and royalty terms.


Chapter 3 provides a review of the leading Academic and NonProfit deals since 2012. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.


Chapter 4 provides a comprehensive listing of the top 50 most active companies in Academic and NonProfit dealmaking with a brief summary followed by a comprehensive listing of Academic and NonProfit deals announded by that company, as well as contract documents, where available.


Chapter 5 provides a comprehensive and detailed review of Academic and NonProfit partnering deals signed and announced since Jan 2012, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.


Chapter 6 provides a comprehensive and detailed review of Academic and NonProfit partnering deals signed and announced since Jan 2012. The chapter is organized by specific technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


A comprehensive series of appendices is provided organized by Academic and NonProfit partnering company AZ, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


The report also includes numerous tables and figures that illustrate the trends and activities in Academic and NonProfit partnering and dealmaking since 2012.


In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Academic and NonProfit technologies and products.


Key benefits


Global Academic and NonProfit Partnering 20122018: Deal trends, players, financials and forecasts provides the reader with the following key benefits:


Indepth understanding of Academic and NonProfit deal trends since 2012

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Academic and NonProfit agreements with real life case studies

Detailed access to actual Academic and NonProfit contracts entered into by leading biopharma companies

Identify most active Academic and NonProfit dealmakers since 2012

Insight into terms included in a Academic and NonProfit partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Academic and NonProfit Partnering 20122018: Deal trends, players, financials and forecasts is intended to provide the reader with an indepth understanding and access to Academic and NonProfit trends and structure of deals entered into by leading companies worldwide.


Academic and NonProfit Partnering Terms and Agreements includes:


Trends in Academic and NonProfit dealmaking in the biopharma industry since 2012

Analysis of Academic and NonProfit deal structure

Access to headline, upfront, milestone and royalty data

Case studies of reallife Academic and NonProfit deals

Access to Academic and NonProfit contract documents

Leading Academic and NonProfit deals by value since 2012

Most active Academic and NonProfit dealmakers since 2012


In Global Academic and NonProfit Partnering 20122018: Deal trends, players, financials and forecasts, the available deals are listed by:


Company AZ

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type


Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The Global Academic and NonProfit Partnering 20122018: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 4,000 Academic and NonProfit deals.


Analyzing actual contract agreements allows assessment of the following:


What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How aresalesand payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Original Article: Global Academic and NonProfit Partnering Terms and Agreements 20122018: Deal trends, players and financials [Report Updated: 01032018] Prices from USD $2995

NEXT ARTICLE

More From BioPortfolio on "Global Academic and NonProfit Partnering Terms and Agreements 20122018: Deal trends, players and financials [Report Updated: 01032018] Prices from USD $2995"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...